Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Zhihua Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5784-9724; OpenAlex author ID A5100406760. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Tumor-derived miR-203a-3p potentiates muscle wasting by inducing muscle ferroptosis in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2025.217523↗
  2. MiR-19 enhances pancreatic cancer progression by targeting PTEN through PI3K/AKT signaling pathway. Last author DOI 10.26355/eurrev_202002_20160↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yumeng Hu · 1 shared paper, 2025 · strength 0.22
  2. Shaobo Zhang · 1 shared paper, 2025 · strength 0.22
  3. Mingyang Liu · 1 shared paper, 2025 · strength 0.22
  4. Fangxia Wang · 1 shared paper, 2025 · strength 0.22
  5. Yongxing Du · 1 shared paper, 2025 · strength 0.22
  6. Jingyong Xu · 1 shared paper, 2025 · strength 0.22
  7. G-F Zhang · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.